disponibile in formato PDF - Stampa alternativa

■ House of Lords Select Committee on Science and Technology, Cannabis:
the Scientific and Medical Evidence. Ninth Report, London, 1998 (la traduzione
italiana del rapporto è disponibile su www.fuoriluogo/quaderni)
■ Jansen, E.M., et al., “Distribution of Cannabinoid Receptors in Rat Brain
Determined with Aminoalkylindoles”, Brain Res, vol. 575, 1992, pp. 93-102.
■ Joy, J.E., Watson, S.J., Jr., Benson, J.A. (a cura di), Marijuana and Medicine:
Assessing the Science Base, Institute of Medicine, Washington D.C., National
Academy Press, 1999.
■ Karler, R., Turkanis, S.A., “The Cannabinoids as Potential Antiepileptics”, J
Clin Pharmacol, 21(8-9Suppl), 1981, 437S-48S.
■ Karniol, I.G., et al., “Cannabidiol Interferes with the Effects of delta-9tetrahydrocannbinol
in Man”, in: European Journal of Pharmacology, vol. 28,
1975, pp. 172-177.
■ Kaufman, P.L., “Marijuana and Glaucoma”, Arch Ophthalmol, vol. 116, 1998,
pp. 1512-1513.
■ Klein, T.W., Newton, C.A., Friedman, H., “Cannabinoid Receptors and
Immunity”, Immunol Today, vol. 19, 1998, pp. 373-380.
■ Klein, T.W., Newton, C.A., Friedman, H., “Cannabinoids and the Immune
System”, in: Pain Res Manag, vol. 6, 2001, pp. 95-101.
■ Kluin-Neleman, J.C., et al., “Delta9-tetrahydrocannabinol (THC) as an
Antiemetic for Patients Receiving Cancer Chemotherapy; a Double Blind
Cross-over Trial against Placebo”, in: Vet Hum Toxicol, vol. 21, 1979, pp. 228-
240.
■ Knoller, N., et al., “Dexanabinol in the Treatment of Severe Closed Head
Injury: A Randomized, Placebo-controlled, Phase II Clinical Trial”, in: Crit Care
Med, vol. 30(3), 2002, pp. 548-554.
■ Kosel, B.W., et al., “The Effects of Cannabinoids on the Pharmacokinetics
of Indinavir and Nelfinavir”, in: AIDS, Mar 8;16(4), 2002, pp. 543-550.
■ Lichtman, A.H., Cook, S.A., Martin, B.R., “Investigation of Brain Sites
Mediating Cannabinoid-induced Antinociception in Rats: Evidences
Supporting Periaqueductal Gray Involvement”, in: J Pharmacol Exp Ther, vol.
276(2), 1996, pp. 585-593.
■ Malec, J., Harvey, R.F., Cayner, J.J., “Cannabis Effect on Spasticity in Spinal
Cord Injury”, in: Arch Phys Med Rehabil, vol. 63(3), 1982, pp. 116-118.
■ Malfait, A.M., Gallily, R., Sumariwalla, P.F., Malik, A.S., Andreakos, E.,
Mechoulan, R., Feldmann, M., “The Nonpsychoactive Cannabis Constituent
Cannabidiol is an Oral Anti-arthritic Therapeutic in Murine Collagen-induced
Arthritis”, in: Proc Natl Acad Sci USA, vol. 97, 2000, pp. 9561-9566.
■ Mason D.J., Jr., Lowe, J., Welch,S.P., “Cannabinoid Modulation of
Dynorphin A: Correlation to Cannabinoid-induced Antinociception”, in: Eur. J.
Pharmacol., vol. 378, 1999, pp. 237-248.
132